Study in efficacy and safety outcomes of Micropulse transscleral cyclophotocoagulation Using Different Sweep Velocity in the treatment of uncontrolled glaucoma Micropulse Transscleral Cyclophotocoagulation Sweep Velocity Uncontrolled Glaucoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with refractory glaucoma or uncontrolled glaucoma, IOP is not fully controlled with medication or surgery. Patients can't restore vision and patients with conditions unsuitable for surgical treatment. 2. IOP more than or equal 21 mmHg. 3. MP-TSCPC can be performed superior and inferior hemispheres. 4. Age 18-80 years. 5. Patients who consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Patients who have undergone any procedure to reduce IOP in the past 3 months, e.g. laser therapy, Surgery to open the anterior chamber drainage or drainage tube in the anterior chamber. 2) Have area of scleral or conjunctival thinning more than one clock hour. 3) Patients who are unable to follow up on treatment results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure at 1 week, 1 month, 3 month, 6 month after Micropulse transscleral cyclophotocoagulation Intraocular pressure after Micropulse transscleral cyclophotocoagulation measure by Goldmann applanation tonometry | — |
Secondary
| Measure | Time frame |
|---|---|
| glaucoma medication at 1 week, 1 month, 3 month, 6 month after Micropulse transscleral cyclophotocoagulation number of glaucoma medication after Micropulse transscleral cyclophotocoagulation,Best-corrected visual acuity at 1 week, 1 month, 3 month, 6 month after Micropulse transscleral cyclophotocoagulation best-corrected visual acuity after Micropulse transscleral cyclophotocoagulation | — |
Countries
Thailand
Contacts
Faculty of Medicine Siriraj Hospital, Mahidol University